Investment Rating - The report maintains an "Outperform" rating for ANTA Sports [2][5] Core Insights - ANTA Brand experienced its first low-single-digit negative sell-through growth in 4Q25 after 11 consecutive quarters of positive growth, primarily due to offline sales decline and challenges in the children's category, although it still achieved a full-year low-single-digit growth target [3][10] - FILA Brand achieved mid-single-digit sell-through growth in both 4Q25 and for the full year 2025, with increased discounts and a stock-to-sales ratio slightly above 5x [3][10] - Management is cautious about 2026, planning increased investments in brand and marketing due to significant sporting events such as the Milan Winter Olympics, World Cup, and Asian Games [3][10] Financial Summary - Revenue projections for ANTA Sports from 2025 to 2027 are RMB 78.26 billion, RMB 85.00 billion, and RMB 92.04 billion, representing year-on-year growth of 10.5%, 8.6%, and 8.3% respectively [5][12] - Net profit attributable to parent shareholders is expected to be RMB 12.98 billion, RMB 14.34 billion, and RMB 16.24 billion for the same years, with year-on-year changes of -13.1%, 14.6%, and 13.8% respectively [5][12] - The corresponding P/E ratios for 2025 to 2027 are projected at 16.0x, 14.5x, and 12.8x [5][12]

Investment Rating - The report maintains a "Buy" rating for Anta Sports [6] Core Insights - In Q4 2025, Anta's retail performance showed resilience despite a weak market, with Anta brand and Fila brand revenues experiencing low single-digit and mid-single-digit growth respectively, while other brands saw a growth of 35-40% [1][2] - The company continues to advance its multi-brand strategy and global expansion, launching innovative products and entering new markets, including a three-year plan for Southeast Asia and partnerships in Europe [3][4] Summary by Relevant Sections Retail Performance - In Q4 2025, Anta brand revenue declined slightly, while Fila brand revenue improved to mid-single-digit growth, and other brands grew by 35-40% [1][2] - For the full year, Anta brand and Fila brand revenues grew low single-digit and mid-single-digit respectively, while other brands achieved a growth of 45-50%, leading to a double-digit overall revenue growth for the year [1] Multi-Brand Strategy - Anta Sports is recognized as a leading multi-brand sports group, with clear brand positioning and steady expansion [3] - The company launched several innovative products and technologies in 2025, including a fluorine-free fabric and an AI innovation platform [3] Global Expansion - Anta is focusing on expanding its main brand overseas, with plans for a thousand stores in Southeast Asia and initiatives in Europe and the Middle East [3][4] - The Fila brand has initiated a three-year partnership in tennis, enhancing its professional sports image [3] Financial Projections - The report adjusts the profit forecast for 2025-2027 down by 1%-3% due to short-term uncertainties, projecting EPS of 4.69, 5.10, and 5.67 RMB for 2025-2027 respectively, with corresponding P/E ratios of 16, 14, and 13 [4]

Investment Rating - The report assigns a "Buy" rating for the company, YuRan Dairy [5] Core Insights - The company is positioned as a leading player in China's dairy industry, with both a strong market position and undervalued stock, benefiting from the upward cycle of beef cattle and the reversal of raw milk prices, which is expected to lead to high returns from cattle disposal and significant growth in raw milk production [1][2] - The raw milk price is nearing a turning point, with a projected decline in dairy cow inventory by 8% from the end of 2023 to October 2025, which is expected to support a moderate increase in milk prices [1] - The company has established the largest modern dairy farm network in China, operating 100 farms across 17 provinces, with a dairy cow inventory of 620,000 heads and a raw milk production of 2.08 million tons in the first half of 2025, leading the industry [1][18] Summary by Sections 1. Company Overview - YuRan Dairy is a leader in the upstream dairy market, covering the entire industry chain from breeding to raw milk production, and is committed to high-quality development and sustainable practices [17] - The company has a stable shareholding structure, with a significant stake held by Yili Group, which also serves as a core customer, ensuring a deep business relationship [22] 2. Beef Cattle Market - The beef cattle market is expected to experience a structural shortage due to a decline in breeding cows, which will support long-term price increases [2][47] - The company is projected to benefit from the rising prices of calves and breeding cattle, with expected revenue growth from cattle disposal of 72% in 2025 [2] 3. Raw Milk Market - The raw milk business is expected to see significant growth, with sales projected to exceed 4 million tons by 2025, benefiting from cost reductions and efficiency improvements [1][3] - The company has a strong sales relationship with Yili, with 94.8% of its raw milk sales going to Yili at a price significantly higher than the industry average [1] 4. Financial Projections - Revenue is expected to grow from 200.96 billion yuan in 2024 to 258.98 billion yuan in 2027, with net profit projected to increase from a loss of 691 million yuan in 2024 to a profit of 4.01 billion yuan in 2027 [11][9] - The company’s price-to-earnings ratio is projected to decrease significantly, indicating a potential for valuation improvement [9] 5. Market Dynamics - The report highlights the cyclical nature of the dairy and beef markets, with a turning point expected in the raw milk cycle and a long-term upward trend in beef prices due to structural supply issues [1][68] - The company is well-positioned to capitalize on these market dynamics, with a robust operational framework and strategic partnerships [1][4]

Investment Rating - The investment rating for Anta Sports is "Buy" with a target price not specified [1] Core Views - The report indicates that Anta's main brand experienced a slight decline in revenue in Q4 2025, while FILA and other brands showed varying growth rates [2][3] - The company plans to open a total of 7,000-7,100 Anta stores, 2,600-2,700 Anta Children stores, and 2,100-2,200 FILA stores by the end of 2025 [4] - The report maintains revenue and net profit forecasts for 2025, 2026, and 2027, with expected revenues of 770 billion, 859 billion, and 960 billion respectively, and net profits of 138.74 billion, 159.07 billion, and 178.76 billion [4] Summary by Sections Event Overview - In Q4 2025, Anta's main brand and FILA experienced low single-digit negative growth, while other brands saw mid-single-digit positive growth [2] Analysis and Judgment - Anta's brand saw a decline in Q4 2025 due to delayed Spring Festival affecting children's sales, while FILA's revenue showed mid-single-digit growth [3] - Other brands like Descente, KOLON, and MAIA experienced growth rates of 35-40%, which is a slowdown compared to previous quarters [3] Investment Recommendations - Short-term outlook suggests pressure on Anta's children's segment and e-commerce, but a potential recovery in 2026 for the main brand [4] - Mid-term growth is expected for KOLON and DESCENTE due to favorable outdoor market conditions [4] - Long-term growth drivers include brands like Jack Wolfski, MUSINS, and MAYA ACTIVE [4] Financial Forecasts and Valuation - Revenue projections for 2025, 2026, and 2027 are 770.45 billion, 859.48 billion, and 959.63 billion respectively, with net profit forecasts of 138.74 billion, 159.07 billion, and 178.76 billion [6][9] - The report maintains EPS forecasts of 4.94, 5.67, and 6.37 for the respective years [6][9]

Investment Rating - The report assigns a "Buy" rating for the company, YuRan Dairy [5] Core Insights - The company is positioned as a leading player in China's dairy industry, with both a strong market position and undervalued stock, benefiting from the upward cycle of beef cattle and the reversal of raw milk prices, which is expected to lead to high returns from cattle disposal and significant growth in raw milk production [1][2] - The raw milk price is nearing a turning point, with current prices at the bottom of the cycle, and a projected decline in dairy cow inventory by 8% by October 2025 compared to the end of 2023, which will support a moderate increase in milk prices [1] - The company has established the largest modern dairy farm network in China, operating 100 farms across 17 provinces, with a dairy cow inventory of 620,000 heads and a raw milk production of 2.08 million tons in the first half of 2025, ranking first in the country [1][18] Summary by Sections 1. Company Overview - YuRan Dairy is a leader in the upstream dairy market in China, covering the entire industry chain from breeding to raw milk production, and is committed to high-quality development and sustainable practices [17] - The company has a stable shareholding structure, with Yili Group as the largest shareholder, holding 33.93% of the shares, which strengthens the business relationship and sales advantages [22] 2. Beef Cattle Market - The beef cattle market is expected to experience a structural shortage, supporting long-term price increases due to a significant reduction in inventory and a weak replenishment of breeding cows [2][38] - The company is projected to benefit from the rising prices of calves and breeding cattle, with expected revenue growth from cattle disposal of 72% in 2025, 25% in 2026, and 34% in 2027 [2] 3. Raw Milk Market - The raw milk business is expected to have high growth elasticity, with a projected sales volume exceeding 4 million tons by 2025, benefiting from cost reduction and efficiency improvements [1][3] - The company’s raw milk sales to Yili accounted for 94.8% of its total raw milk revenue, with a selling price of 3.87 yuan/kg, which is 25.6% higher than the industry average [1] 4. Financial Projections - The company’s revenue is expected to grow steadily, with projected revenues of 215.89 billion yuan in 2025, 234.86 billion yuan in 2026, and 258.98 billion yuan in 2027, reflecting growth rates of 7.43%, 8.78%, and 10.27% respectively [9] - The net profit is projected to recover significantly, with estimates of 9.71 billion yuan in 2025, 20.37 billion yuan in 2026, and 40.10 billion yuan in 2027, corresponding to growth rates of 240.60%, 109.67%, and 96.88% respectively [9][11]

Investment Rating - The report assigns a "Buy" rating for Shenzhen International (00152) [2] Core Views - Shenzhen International is controlled by the Shenzhen State-owned Assets Supervision and Administration Commission and holds quality assets in the Greater Bay Area [8] - The logistics business serves as a solid foundation, with REITs spin-offs and logistics park upgrades opening up profit elasticity [8] - The toll road and port businesses provide stable profit contributions, with a central profit contribution of approximately HKD 1.1 billion [18] Summary by Relevant Sections 1. Control and Asset Management - Shenzhen International is a state-owned enterprise under the Shenzhen State-owned Assets Supervision and Administration Commission, focusing on urban support development and operations [13][14] 2. Logistics Business Development - The logistics business is centered around logistics parks, with an operational area of 6.71 million square meters as of H1 2025, and a compound annual growth rate of 24.07% from 2014 to 2024 [23][24] - The company has completed the REITs spin-off for five projects, contributing a total of HKD 14.2 billion to net profit as of H1 2025 [8][38] - The logistics park projects are expected to generate significant land appreciation and development profits, with projected after-tax returns of HKD 136.5 billion from the South China logistics park project [60][62] 3. Toll Road and Port Business - The toll road and port operations are managed by subsidiaries, contributing a stable profit base with a net profit of HKD 4.9 billion in H1 2025 [65] - The company holds approximately 47.3% equity in Shenzhen Expressway, which operates 16 toll road projects with a total toll mileage of 613 kilometers [66] 4. Financial Projections - The company is expected to achieve revenues of HKD 17.06 billion, HKD 17.61 billion, and HKD 18.75 billion for the years 2025, 2026, and 2027 respectively, with corresponding net profits of HKD 3.17 billion, HKD 3.47 billion, and HKD 3.53 billion [6][8]

Investment Rating - The report assigns a "Buy" rating to the company [3]. Core Insights - The company is positioned as a "national brand" aiming for global expansion, leveraging its technological advancements and multi-brand strategy to drive growth [8]. - The company has established a comprehensive technology stack and a diverse brand matrix to cater to various consumer needs, focusing on both domestic and international markets [8]. - The financial outlook is strong, with significant revenue and profit growth projected over the next few years, supported by a robust international presence and innovative product offerings [8]. Financial Summary - The company’s revenue is projected to grow from RMB 163.21 billion in 2023 to RMB 454.24 billion by 2027, with growth rates of 76.2% in 2023 and 17.9% in 2027 [2]. - EBITDA is expected to increase from RMB 17.40 billion in 2023 to RMB 40.37 billion in 2027 [2]. - Net profit attributable to shareholders is forecasted to rise from RMB 11.95 billion in 2023 to RMB 24.96 billion in 2027, with a notable growth rate of 90.8% in 2023 [2]. - The earnings per share (EPS) is anticipated to grow from RMB 2.19 in 2023 to RMB 4.30 in 2027, with a price-to-earnings (P/E) ratio projected to decrease from 8.8 in 2025 to 6.4 in 2027 [2]. Business Model - The company operates primarily in the passenger vehicle sector, with a revenue share of 91.5% from passenger vehicles in 2024 [25]. - The brand matrix includes five major brands: Chery, Jietu, Xingtu, iCAR, and Zhijie, each targeting different market segments [25]. - The company has a strong international presence, with overseas revenue expected to reach RMB 1,008.97 billion by 2024, accounting for 46.3% of total revenue [32]. Future Outlook - The company aims to enhance its product offerings and expand its global footprint through strategic investments in R&D and international operations [54]. - The focus on new energy vehicles (NEVs) is expected to drive significant revenue growth, with NEV revenue projected to reach RMB 589.31 billion in 2024, representing a year-on-year increase of 644.8% [44]. - The company is committed to continuous innovation and technological advancement, positioning itself as a leader in the evolving automotive landscape [8].

Investment Rating - The report maintains a "Buy" rating for Yadea Holdings (1585.HK) with a target price of HKD 16.43, indicating a potential upside of 37.5% from the current price of HKD 11.95 [1][7][14]. Core Insights - The company announced a significant profit increase for 2025, with an expected net profit of at least RMB 2.9 billion, representing a growth of over 128% compared to RMB 1.27 billion in 2024. This increase is attributed to higher sales of electric two-wheelers and optimized product structure [4][9]. - The new national standard for electric bicycles is set to stabilize the market post-Chinese New Year 2026, as the transition period for old standard products ends, which is expected to restore consumer purchasing willingness [5][10]. - Yadea is focusing on long-term growth through continuous investment in R&D and marketing, enhancing its product competitiveness and global marketing capabilities. In H1 2025, the company sold approximately 8.79 million electric scooters and bicycles, a year-on-year increase of about 37.8%, with a gross margin rising to 19.6% [6][11]. Financial Summary - Revenue projections for Yadea from 2025 to 2027 are RMB 35.78 billion (+26.7%), RMB 40.48 billion (+13.1%), and RMB 45.59 billion (+12.6%) respectively. The net profit forecasts are RMB 2.99 billion (+135%), RMB 3.25 billion (+8.8%), and RMB 3.55 billion (+9.3%) [12][8]. - The company's gross margin is expected to improve from 18.7% in 2025 to 19.8% in 2027, reflecting ongoing enhancements in product structure and sales volume [8].

Investment Rating - The report gives a "Strong Buy" rating for the company, marking its first coverage [3]. Core Insights - The company is transitioning into a new phase characterized by innovation and internationalization, with a focus on commercializing innovative drugs and expanding into emerging markets [1][7]. - The impact of centralized procurement on core products is expected to stabilize, leading to a recovery in revenue and profit growth starting in 2024 [7][13]. - The company has a robust pipeline of nearly 40 innovative drug candidates, with several expected to launch commercially in 2024 [7][23]. Financial Data and Valuation - Total revenue is projected to decline from 8,013 million in 2023 to 7,469 million in 2024, before increasing to 10,061 million by 2026 [2]. - Net profit is expected to decrease from 2,401 million in 2023 to 1,620 million in 2024, with a recovery to 1,955 million by 2026 [2]. - The company’s PE ratio is forecasted to improve from 18.6 in 2024 to 15.4 in 2026, indicating a potential increase in valuation [2]. Business Model and Strategy - The company has evolved from a CSO model to a full-chain innovative pharmaceutical enterprise, focusing on specialized fields such as dermatology and ophthalmology [11][18]. - The internationalization strategy includes expanding into Southeast Asia and the Middle East, with nearly 20 drug applications submitted in these regions [7][11]. - The company plans to spin off its dermatology business, Demy Pharma, for independent listing, enhancing its focus on specialized markets [7][11]. Product Pipeline and Market Potential - The innovative product pipeline includes five drugs that have already been commercialized, with additional candidates in various stages of development [20][24]. - Key products such as Vifor (for chronic kidney disease) and Y-3 (for acute ischemic stroke) are expected to drive future growth [29][37]. - The company is targeting significant unmet medical needs in the Chinese market, particularly in areas like high phosphorus levels in dialysis patients and rabies passive immunity [31][47].

Investment Rating - The report maintains a "Buy" rating for Yadea Holdings, with a target price of HKD 16.43, indicating a potential upside of 37.5% from the current price of HKD 11.95 [1][7][14]. Core Insights - The company has announced a significant profit increase for 2025, with an expected net profit of at least RMB 2.9 billion, representing a growth of over 128% compared to RMB 1.27 billion in 2024. This increase is attributed to higher sales of electric two-wheelers and optimized product structure [4][9]. - The new national standard for electric bicycles is set to stabilize the market post-Chinese New Year 2026, as the transition period for old standard products will end, leading to a gradual recovery in consumer purchasing willingness [5][10]. - Yadea is focusing on long-term growth through continuous investment in R&D and marketing, enhancing its product competitiveness and global marketing capabilities. In H1 2025, the company sold approximately 8.79 million electric scooters and bicycles, a year-on-year increase of about 37.8%, with a gross margin rising to 19.6% [6][11]. Financial Summary - Revenue projections for Yadea from 2025 to 2027 are RMB 35.78 billion (+26.7%), RMB 40.48 billion (+13.1%), and RMB 45.59 billion (+12.6%) respectively. The net profit forecasts are RMB 2.99 billion (+135%), RMB 3.25 billion (+8.8%), and RMB 3.55 billion (+9.3%) [12][8]. - The company's gross margin is expected to improve from 18.7% in 2025 to 19.8% in 2027, reflecting ongoing enhancements in product structure and sales volume [8][12].